✦ LIBER ✦

Impact of paroxetine on sleep problems in 426 cancer patients receiving chemotherapy: A trial from the University of Rochester Cancer Center Community Clinical Oncology Program

✍ Scribed by Palesh, Oxana G.; Mustian, Karen M.; Peppone, Luke J.; Janelsins, Michelle; Sprod, Lisa K.; Kesler, Shelli; Innominato, Pasquale F.; Roth, Thomas; Manber, Rachel; Heckler, Charles; Fiscella, Kevin; Morrow, Gary R.

Book ID: 122784612
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 236 KB
Volume: 13
Category: Article
ISSN: 1389-9457
DOI: 10.1016/j.sleep.2012.06.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 3 randomized, placebo-controlled

A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy : A University of Rochester Cancer Center Community Clinical Oncology Program Research base study

✍ Pascal Jean-Pierre; Gary R. Morrow; Joseph A. Roscoe; Charles Heckler; Supriya M 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 1 views

Nausea and emesis remain significant pro

Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics : A University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program study of 360 cancer patients treated in the community

✍ Jane T. Hickok; Joseph A. Roscoe; Gary R. Morrow; David K. King; James N. Atkins 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Abstract ## BACKGROUND Clinical reports suggest that nausea remains a side effect of chemotherapy despite widespread use of serotonin receptor antagonists. This study summarized the frequency, timing, and intensity of postchemotherapy nausea for patients receiving doxorubicin, cisplatin, or car

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views